Showing results (241-250 of 253) with videos related to

Sort By:
Pageof 26
Experimental Parasitology|January 10, 2017
Extended-spectrum antiprotozoal bumped kinase inhibitors: A reviewWesley C Van Voorhis, J Stone Doggett, Marilyn Parsons, et al.
The Journal of Infectious Diseases|October 27, 2023
An Early Treatment With BKI-1748 Exhibits Full Protection Against Abortion and Congenital Infection in Sheep Experimentally Infected With Toxoplasma gondiiRoberto Sánchez-Sánchez, Dennis Imhof, Yanina P Hecker, et al.
International Journal of Antimicrobial Agents|July 25, 2020
Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in miceNicoleta Anghel, Pablo A Winzer, Dennis Imhof, et al.
International Journal for Parasitology. Drugs and Drug Resistance|April 9, 2019
Bumped kinase inhibitor 1369 is effective against Cystoisospora suis in vivo and in vitroAruna Shrestha, Kayode K Ojo, Florian Koston, et al.
International Journal for Parasitology. Drugs and Drug Resistance|October 16, 2021
A short-term treatment with BKI-1294 does not protect foetuses from sheep experimentally infected with Neospora caninum tachyzoites during pregnancyRoberto Sánchez-Sánchez, Ignacio Ferre, Michela Re, et al.
International Journal for Parasitology. Drugs and Drug Resistance|March 5, 2018
Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoitesRoberto Sánchez-Sánchez, Ignacio Ferre, Michela Re, et al.
Plos Neglected Tropical Diseases|July 30, 2025
Anti-Cryptosporidium efficacy of BKI-1708, an inhibitor of Cryptosporidium calcium-dependent protein kinase 1Ryan Choi, Matthew A Hulverson, Deborah A Schaefer, et al.
Veterinary Parasitology|January 8, 2021
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseasesWesley C Van Voorhis, Matthew A Hulverson, Ryan Choi, et al.
Pageof 26